Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +3 vs. Q2 2022
- Shares held
- 30.3M
- +15.6M (+105.7%) vs. Q2 2022
- Total value
- $178.1M
- +$141.6M (+388.3%) vs. Q2 2022
- New holders
- 16
- 18 more added
- Sold out
- 13
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 122 | $1.00K | 0.00% | +70+134.6% | Added |
| Capital Advisors, Ltd. LLC | 200 | $1.00K | 0.00% | +98+96.1% | Added |
| China Universal Asset Management Co., Ltd. | 353 | $2.00K | 0.00% | +353 | New |
| Citigroup Inc | 701 | $4.00K | 0.00% | +182+35.1% | Added |
| UBS Group AG | 3,667 | $22.0K | 0.00% | +3,667 | New |
| Tower Research Capital LLC (TRC) | 6,601 | $39.0K | 0.00% | −3,879−37.0% | Reduced |
| Morgan Stanley | 7,243 | $42.0K | 0.00% | −11,428−61.2% | Reduced |
| Bank of America Corp | 7,726 | $46.0K | 0.00% | −10,382−57.3% | Reduced |
| Qube Research & Technologies Ltd | 10,809 | $64.0K | 0.00% | −599−5.3% | Reduced |
| Prelude Capital Management, LLC | 10,945 | $64.0K | 0.00% | +10,945 | New |
| Goldman Sachs Group Inc | 11,916 | $70.0K | 0.00% | −4,672−28.2% | Reduced |
| Walleye Capital LLC | 12,124 | $71.0K | 0.00% | +12,124 | New |
| Acadian Asset Management LLC | 12,627 | $74.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 12,408 | $74.0K | 0.00% | +12,408 | New |
| Jane Street Group, LLC | 13,255 | $78.0K | 0.00% | +13,255 | New |
| Silverarc Capital Management, LLC | 14,473 | $85.0K | 0.04% | +14,473 | New |
| Raymond James Financial Services Advisors, Inc. | 20,830 | $123.0K | 0.00% | +20,830 | New |
| Northern Trust Corp | 21,504 | $127.0K | 0.00% | +7,131+49.6% | Added |
| Dimensional Fund Advisors LP | 33,312 | $196.0K | 0.00% | +33,312 | New |
| Caas Capital Management LP | 85,851 | $213.0K | 0.03% | −11,661−12.0% | Reduced |
| State Street Corp | 42,037 | $248.0K | 0.00% | +22,200+111.9% | Added |
| Bridgeway Capital Management, LLC | 69,500 | $409.0K | 0.01% | +24,000+52.7% | Added |
| HighVista Strategies LLC | 77,344 | $456.0K | 0.26% | +77,344 | New |
| FMR LLC | 101,639 | $599.0K | 0.00% | −360.0% | Reduced |
| Boothbay Fund Management, LLC | 135,719 | $799.0K | 0.03% | +29,007+27.2% | Added |
| Renaissance Technologies LLC | 152,200 | $896.0K | 0.00% | −32,216−17.5% | Reduced |
| Geode Capital Management, LLC | 168,848 | $994.0K | 0.00% | +89,524+112.9% | Added |
| Commodore Capital LP | 205,870 | $1.21M | 0.20% | +205,870 | New |
| BlackRock Inc. | 286,293 | $1.69M | 0.00% | +136,765+91.5% | Added |
| Samsara BioCapital, LLC | 289,068 | $1.70M | 0.40% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 350,702 | $2.07M | 0.92% | +350,702 | New |
| Millennium Management LLC | 382,713 | $2.25M | 0.00% | +105,025+37.8% | Added |
| Armistice Capital, LLC | 600,000 | $3.53M | 0.09% | +276,984+85.7% | Added |
| Vanguard Group Inc | 619,132 | $3.65M | 0.00% | +251,603+68.5% | Added |
| Barclays PLC | 659,098 | $3.88M | 0.00% | +645,973+4,921.7% | Added |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $4.21M | 1.53% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 728,600 | $4.29M | 0.65% | +728,600 | New |
| Ikarian Capital, LLC | 904,119 | $5.33M | 2.66% | +204,119+29.2% | Added |
| JPMorgan Chase & Co | 919,042 | $5.41M | 0.00% | +918,079+95,335.3% | Added |
| Driehaus Capital Management LLC | 1,597,929 | $9.41M | 0.14% | +1,387,855+660.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,860,000 | $11.0M | 0.22% | +1,860,000 | New |
| Fairmount Funds Management LLC | 2,050,000 | $12.1M | 2.23% | +2,050,000 | New |
| VR Adviser, LLC | 3,707,891 | $21.8M | 3.37% | +3,707,891 | New |
| Vivo Capital, LLC | 5,899,372 | $34.7M | 3.84% | +3,224,239+120.5% | Added |
| OrbiMed Advisors LLC | 7,481,204 | $44.1M | 0.88% | +3,690,000+97.3% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,261,435−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,238,800−100.0% | Sold out |
| Antara Capital LP | 0 | $0 | 0.00% | −874,600−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −401,268−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −63,454−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −57,876−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −38,810−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,428−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −14,097−100.0% | Sold out |